Subscribe to RSS feeds Bulkowski Blog via RSS

Thomas Bulkowski’s successful investment activities allowed him to retire at age 36. He is an internationally known author and trader with 30 years of stock market experience and widely regarded as a leading expert on chart patterns. His four books, including the best selling Encyclopedia of Chart Patterns, have been translated into seven languages. He may be reached at

Support this site! Clicking on his books below takes you to Amazon.com. If you buy ANYTHING, they pay for the referral.

Bulkowski's FDA Drug Approvals

Elliott
Wave
Funda-
mentals
Indicators Market
Review
Pattern
Rank
Psychology Quiz Research Software Test
Portfolios
Trading
Class
Trading
Setups
Tutorial Watch
List
ThePatternSite.com logo Busted
Patterns
Candles Chart
Patterns
Event
Patterns
Scoring
Patterns
Volume
Patterns
ThePatternSite.com logo
Market
Industrials (^DJI):
Transports (^DJT):
Utilities (^DJU):
Nasdaq (^IXIC):
S&P 500 (^GSPC):
As of 02/06/2012
12,845 -17.10 -0.1%
5,334 -34.68 -0.6%
450 -1.41 -0.3%
2,902 -3.67 -0.1%
1,344 -0.57 0.0%
YTD
5.1%
6.3%
-3.2%
11.4%
6.9%
Tom's Targets    Overview: 02/03/2012
13,100 or 12,400 by 02/15/2012
5,500 or 5,150 by 02/15/2012
470 or 440 by 02/15/2012
3,100 or 2,800 by 02/15/2012
1,375 or 1,300 by 02/15/2012
Mutt Losers: None YTD
Wilder RSI: None YTD

Written by and copyright © 2005-2011 by Thomas N. Bulkowski. All rights reserved.

For more information on this pattern, read Encyclopedia of Chart Patterns, Second Edition, pictured on the right, pages 880 to 892. That chapter gives a complete review of the event pattern, including tour, identification guidelines, focus on failures, performance statistics, trading tactics, and sample trade. Below is just a sliver of the information contained in the book.

When the FDA approves a drug and it's announced to the public, price can breakout in any direction, but the probabilities say that price will trend down soon after. This event pattern isn't worth trading because it has such poor performance. Discovered by Thomas Bulkowski in the summer of 2003.

 

FDA drug announcement event pattern

Ideal FDA Drug Announcement Pattern

Important Market Results for Upward Breakouts, FDA Drug Approvals

Overall performance rank (1 is best): 6 out of 6
Break even failure rate: 34%
Average rise: 20%
Throwback rate: 61%
Percentage meeting price target: 81%

The above numbers are based on hundreds of perfect trades. See the glossary for definitions.

FDA Drug Approval Identification Guidelines

CharacteristicDiscussion
AnnouncementNews outlets report that the FDA has approved a drug.
Wide swingLook for announcements in which price makes a large intraday price swing, preferably 2 or 3 times the average intraday range over the last month.
Yearly highFor best performance after an upward breakout, select announcements that occur within a third of the yearly high.
Upward breakoutA breakout occurs when price closes above the high posted on the announcement day.
VolumeSelect patterns with heavy announcement day volume, above the 30-day average.

Top 

FDA Drug Approval Trading Tips

Although I don't recommend trading this event pattern, there is an inverted J-shaped pattern (inverted and descending scallop) that shows promise. The following (except the measure rule which refers to all upward breakouts) pertains to that situation. A study of the pattern reveals that price declines an average of 29% in 86 days after an upward breakout.

Trading TacticExplanation
Measure ruleCompute the height (intraday high minus the low) on the announcement day and multiply it by the above "percentage meeting price target." Add the result to the intraday high to get a price target.
Inverted J-shapeFor upward breakouts, look for a price pattern that is an inverted J-shape. Price moves up following a trend, rounds over, and heads back down. The figure to the right shows what this pattern looks like.
Price riseAfter the breakout, price rises between 3 and 6 weeks before beginning to slide. Ignore patterns outside that time limit.
TrendlinePrice follows a trend moving higher. A trendline drawn along the bottom of that price trend, when pierced by moving lower, is the sell or sell short signal. The ideal figure near the top of this page shows an example.
Inverted J-shaped event pattern
Inverted J-Shape

Top 

FDA Drug Approval Example

FDA approves drug example

The above figure shows an example of what happens sometimes when the FDA approves a drug. News reports indicated that the company and its partner received approval to sell Abilify in the U.S. Price gapped up on the news and a nice rise followed. However, within a few weeks, the stock was moving down again, bottoming in March.

-- Thomas Bulkowski

Top 

See Also

Copyright © 2005-2011 by Thomas N. Bulkowski. All rights reserved. A fool and your money are soon partners.